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ABSTRACT: 
 
  In this study parthenolide content of feverfew 
product (Tanamigraine capsule) and apigenin content of 
chamomile products (Chamomill drop, Kamisol solution, 
Prostatan drop, Prostatan tablet) were determined as 
effective compound by HPLC. Feverfew product was 
extracted by methanol/distilled de-ionized water (50: 50) 
and chamomile products by methanol. The HPLC operating 
conditions were C-18 reversed phase column (VP-ODS 
250×4.6 mm, 5 mm), methanol/ distilled de-ionized water 
(60: 40) as the mobile phase at a flow rate of 1 ml/min and 
UV detection at 214 nm for parthenolide and 2% acetic 
acid: acetonitril with linear program 80 to 40 % of acetic 
acid 2% with a flow rate of 1 ml/min and UV detection at 
275nm for apigenin. The amount of parthenolide and 
apigenin obtained in Tanamigraine capsules and chamomile 
products is 0.13- 016% and 0.04- 35% respectively. 
 
 
 
 
 
INTRODUCTION 
 
Feverfew (Tanacetum pantheism) is a medicinal 
herb which includes germacranolides, eg. parthenolide and 
flavonoids among others. It has traditionally been used in 
the treatment of migraine, tinnitus, vertigo, arthritis, fever, 
menstrual disorder, and difficulty during labour, 
stomachache, toothache and insect bites (1). Sesquiterpene 
lactones, especially parthenolide are the active component 
in feverfew (2). Interest in feverfew, however, has 
dramatically increased since the publication of two double-
blind placebo controlled clinical trial in England. These 
studies clearly established the potential of feverfew in the 
prophylaxis of migraine (3). The mechanism of migraine 
prevention by feverfew has not been completely 
established, many researchers have stated that bioactive 
component corresponding for the pharmacological 
functionality is parthenolide (4). Its pharmacological action 
is similar to that of aspirin. Parthenolide helps to prevent 
excessive clumping of platelets and inhibits the release of 
certain chemicals, including cerotonin and some 
inflammatory mediators (5). The studies also show that 
parthenolide was effective in inhibition of some tumor cells 
and pro-inflammatory transcriptional nuclear factors NF-
κB (2). 
Chamomile (Matricaria recutita) is another 
herbal medicine and its constituents are coumarins, 
flavonoids such as apigenin, luteolin and quercetin. 
Volatile oil, amino acids, and anthemic acid are also among 
the constituents. Chamomile is stated to possess 
carminative, antispasmodic and anticatarrhal properties. It 
has been used for flatulent nervous dyspepsia, travel 
sickness, nervous diarrhea, and restlessness and especially 
for gastrointestinal disturbance with associated nervous 
irritability in children. One of the active compounds 
identified is apigenin. Apigenin competitively inhibits 
binding of flunitrazepam to the central benzodiazepine 
receptor, but lacked activity at other receptors, including 
muscarinic, α1-adrenoreceptor and GABAΑ. Greatest 
antispasmodic activity was exhibited by the flavonoides, 
especially apigenin which was found to be more than three 
times as potent as papaverine (1). 
In vitro studies have recently determined that at least part 
of the anti-inflammatory activity of chamomile extracts is 
due to constituents which inhibit the formation of 5-
lipoxygenase and cyclooxygenase and have antioxidant 
activity. Apigenin and bisabolol appear to be responsible 
for this activity (6). 
Chamomile extract and some constituents 
demonstrated a dose-dependent antispasmodic effect on 
isolated guinea- pig ileum. The flavones apigenin, luteolin, 
patuletin and quercetin demonstrated marked 
antispasmodic effects. Antispasmodic activity has also been 
observed with oral administration of apigenin. Apigenin 
also demonstrated clear antianxiety and slight sedative 
activity without muscle relaxant in mice. Flavonoids are 
not only adsorbed at the skin surface but penetrate into 
deeper skin layers (6). Apigenin was also reported to 
significantly inhibit UV-induced mouse skin tumor genesis 
(4). 
Commercially available herbal preparations of 
Feverfew (with a claim of “standardized”) were observed to 
vary widely in their parthenolide content and other 
percentage of label claim (7). Physiochemical methods 
were used to measure parthenolide in several commercial 
feverfew products. The results found a wide variation in 
parthenolide content and in some products parthenolide 
was not detected (2). The present study is determination 
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was aimed at developing a sensitive, precise and accurate 
HPLC method for the determination of parthenolide and 
apigenin in some Iranian products and comparing the 
amount found by the proposed method by the labeled 
amount. 
 
Materials and Methods 
Parthenolide standard (Analytik Co.), apigenin 
standard (Analytik.Co), HPLC grade methanol (Darmstadt. 
Merck Co.), distilled de-ionized water, HPLC grade 
acetonitrile (Darmstadt. Merck Co.), acetic acid 2% 
(Darmstadt. Merck Co.). Tanamigraine capsule 
(Zahravi.Co.), Chamomill drop (Amin Co.), Kamisol 
solution (Darok Co.), Prostatan drop (Isfahan Co.), 
Prostatan tablet (Isfahan Co.) were purchased from 
different pharmacies in Tehran. 
 
Chromatographic analysis 
The HPLC system consisted of a pump (LC-
10ADVP Shimadzu) and C-18 reversed-phase column (VP- 
ODS 250L 4.6mm). Feverfew was eluted with a mobile 
phase consisting of methanol and water (60:40) and 
chamomile with a mobile phase consisting of acetic acid 
2% and acetonitrile with linear program 80 to 40 % of 
acetic acid 2% in 25 minutes with a flow rate of 1 ml/min. 
The column effluent was monitored with a variable 
wavelength UV detector at 214 nm for feverfew and at 275 
nm for chamomile (SPD-M 10VP Shimadzu) which has the 
ability to scan from 190-800 nm during compound elution. 
The detector was connected to computer and data were 
analyzed. 
Table2- Apigenin content of chamomile products 
 
Standard curve preparation 
Standard solutions of parthenolide were prepared 
by serial dilution of pure parthenolide resulting in final 
concentrations of 0.25, 0.125, 0.0625, 0.0312 0.0156 
mg/ml. Standard solutions of apigenin was prepared also by 
serial dilution resulting in final concentrations of 0.125, 
0.0625, 0.0312, 0.0156, 0.0078, 0.0039 mg/ml. Each 
standard solution was injected duplicate and in two days 
consequent. Standard curves were constructed by linear 
regression of peak areas and concentrations. 
 
Sample preparation  
The content of 10 Tanamigraine capsules (10 
capsules) were weighed and mixed. An accurately weighed 
portion of this equivalent to 4 capsules was transferred into 
a volumetric flask containing 10 ml methanol distilled de-
ionized water (50/ 50) and shaken for an hour followed by 
centrifugation for 15 min at 3000G. The residue was placed 
in a 10ml volumetric flask to repeat the extraction. The 
supernatant was filtered through a non-aqueous 0.45 µm 
filter.  
 
The liquid chamomile products (1 ml Kamisol 
solution and 5 ml Prostatan drop) were eluted directly by 
methanol to a final volume of 10ml. 10 Prostatan tablets 
were grounded with a mortar and pestle and mixed. 
Equivalent to one tablet was weighed and extracted using 
30 ml methanol and shaken four an hour. The mixture was 
filtered through a non-aqueous 0.45 µm filter. The 
extraction process was repeated three times. 
 
RESULTS 
Quantitative analysis 
In HPLC parthenolide and apigenin peaks in the 
samples were easily identified by comparing their retention 
times with the internal standards of parthenolide and 
apigenin. The samples were injected triplicate. The average 
of results of each product are given in table 1and 2. 
                                 
 Table 1:Parthenolide content of feverfew capsule  
 
 
Brand name 
 
Tanamigraine 125       
(Zahravi Co.) 
 
Label claim 125 mg  
dried of aerial part 
Claimed 
parthenolide in each 
capsule (%) 
 
0.2% 
 
 
 
Calculated 
parthenolide in each 
capsule (%) 
 
0.13- 0.16 
Direction of the 
label 
1-2capsule daily 
Expected daily dose 
parthenolide (mg) 
0.25- 0.5 
Calculated daily 
dose parthenolide 
(mg) 
0.16- 0.4 
 
 
 
 
Precision and accuracy 
Precision of the study was determined by 
calculating intraday CV% (repeatability) and between-day 
CV% (reproducibility) of five standard concentrations. The 
results for parthenolide were 0.037-2.05% and 0.31-2.05% 
Brand name 
(manufacture) 
Label claim 
apigenin content 
(%) 
Calculated apigenin 
content (%) 
Chamomill. 
Drop (Amin 
Co.) 
2 12 
Kamisol 
Solution 
(Darok Co.) 
50-60 35 
Prostatan.Drop 
(Isfahan Co.) - 9.2 
Prostatan.Table
t  
(Isfahan Co.) 
- 0.04 
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and the results for apigenin were 0.8-1.6% and 2-8% for 
intra day and between-day, each respectively. 
Determination of method accuracy was 
performed by injecting triplicate of three different 
concentrations of standard samples. The recovery value has 
been 99.5% for parthenolide (concentrations of 0.0625, 
0.125, 0.25 mg/ml) and 96-98% for apigenin 
(concentrations of 0.05, 0.125, 0.25 mg/ml). 
 
DISCUSSION  
Tanamigrain capsules claimed 125 mg of dried 
aeial parts of feverfew with at least 0.2% parthenolide and 
HPLC analysis revealed 0.13- 0.16% parthenolde present, 
which is not far from labeled amount. The usual 
standardization level of parthenolide content in feverfew 
products is 0.2% (2) which is the serve as labeled amount. 
Table 2 lists label claims for apigenin content and also the 
amounts determined by HPLC.  
 
 
 
Prostatan drop and Prostatan tablet made no 
claims for apigenin content. There is considerable 
difference between label claims and calculated amount of 
apigenin in Chamomile drop and Kamisol 
solution.Unfortunately, a therapeutic dose for apigenin has 
not been approved yet. So there is no possibility to compare 
these two Iranian available chamomile products, 
Chamomill drop and Kamisol solution, have percentage of 
apigenin (mg %) given on the label namely 2% and 50-60% 
respectively.  
 
Our results of apigenin amount in Chamomill 
drop and Kamisol solution are 12% and 35%. As shown, 
the calculated content of apigenin in Chamomill drop is six 
fold higher than its label. But in Kamisol solution the 
claimed apigenin amount could not be detected.  The 
apigenin amount calculated in Prostatan drop and Prostatan 
tablet are 9.2% and 0.04% respectively. Unfortunately no 
measurable data of Apigenin amounts are stated on the 
label of these two products. There is no possibility to match 
the obtained results with the label. 
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